GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (946)
  • 1
    In: Cancer Communications, Wiley, Vol. 38, No. 1 ( 2018-12), p. 1-10
    Abstract: The 8th American Joint Committee on Cancer tumor–node–metastasis (AJCC‐TNM) staging system is based on a few retrospective single‐center studies. We aimed to test the prognostic validity of the staging system and to determine whether a modified clinicopathological tumor staging system that includes lymphovascular embolization could increase the accuracy of prognostic prediction for patients with stage T2–3 penile cancer. Methods A training cohort of 411 patients who were treated at 2 centers in China and Brazil between 2000 and 2015 were staged according to the 8th AJCC‐TNM staging system. The internal validation was analyzed by bootstrap‐corrected C‐indexes (resampled 1000 times). Data from 436 patients who were treated at 15 centers over four continents were used for external validation. Results A survivorship overlap was observed between T2 and T3 patients ( P = 0.587) classified according to the 8th AJCC‐TNM staging system. Lymphovascular embolization was a significant prognostic factor for metastasis and survival (all P 〈 0.001). Based on the multivariate analysis, only lymphovascular embolization showed a significant influence on cancer‐specific survival (CSS) (hazard ratio = 1.587, 95% confidence interval = 1.253–2.011; P = 0.001). T2 and T3 patients with lymphovascular embolization showed significantly shorter CSS than did those without lymphovascular embolization ( P 〈 0.001). Therefore, a modified clinicopathological staging system was proposed, with the T2 and T3 categories of the 8th AJCC‐TNM staging system being subdivided into two new categories as follows: t2 tumors invade the corpus spongiosum and/or corpora cavernosa and/or urethra without lymphovascular invasion, and t3 tumors invade the corpus spongiosum and/or corpora cavernosa and/or urethra with lymphovascular invasion. The modified staging system involving lymphovascular embolization showed improved prognostic stratification with significant differences in CSS among all categories (all P 〈 0.005) and exhibited higher accuracy in predicting patient prognoses than did the 8th AJCC‐TNM staging system (C‐index, 0.739 vs. 0.696). These results were confirmed in the external validation cohort. Conclusions T2–3 penile cancers are heterogeneous, and a modified clinicopathological staging system that incorporates lymphovascular embolization may better predict the prognosis of patients with penile cancer than does the 8th AJCC‐TNM staging system. Trial registration This study was retrospectively registered on Chinese Clinical Trail Registry: ChiCTR16008041 (2016‐03‐02). http://www.chictr.org.cn
    Type of Medium: Online Resource
    ISSN: 2523-3548 , 2523-3548
    Language: English
    Publisher: Wiley
    Publication Date: 2018
    detail.hit.zdb_id: 2922913-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: International Journal of Urology, Wiley, Vol. 17, No. 6 ( 2010-06), p. 517-521
    Type of Medium: Online Resource
    ISSN: 0919-8172
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2009793-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Clinical and Translational Medicine, Wiley, Vol. 13, No. 6 ( 2023-06)
    Abstract: HCFC1 encodes transcriptional co‐regulator HCF‐1, which undergoes an unusual proteolytic maturation at a centrally located proteolysis domain. HCFC1 variants were associated with X‐linked cobalamin metabolism disorders and mental retardation‐3. This study aimed to explore the role of HCFC1 variants in common epilepsy and the mechanism underlying phenotype heterogeneity. Methods Whole‐exome sequencing was performed in a cohort of 313 patients with idiopathic partial (focal) epilepsy. Functional studies determined the effects of the variants on the proteolytic maturation of HCF‐1, cell proliferation and MMACHC expression. The role of HCFC1 variants in partial epilepsy was validated in another cohort from multiple centers. Results We identified seven hemizygous HCFC1 variants in 11 cases and confirmed the finding in the validation cohort with additional 13 cases and six more hemizygous variants. All patients showed partial epilepsies with favorable outcome. None of them had cobalamin disorders. Functional studies demonstrated that the variants in the proteolysis domain impaired the maturation by disrupting the cleavage process with loss of inhibition of cell growth but did not affect MMACHC expression that was associated with cobalamin disorder. The degree of functional impairment was correlated with the severity of phenotype. Further analysis demonstrated that variants within the proteolysis domain were associated with common and mild partial epilepsy, whereas those in the kelch domain were associated with cobalamin disorder featured by severe and even fatal epileptic encephalopathy, and those in the basic and acidic domains were associated with mainly intellectual disability. Conclusion HCFC1 is potentially a candidate gene for common partial epilepsy with distinct underlying mechanism of proteolysis dysfunction. The HCF‐1 domains played distinct functional roles and were associated with different clinical phenotypes, suggesting a sub‐molecular effect. The distinct difference between cobalamin disorders and idiopathic partial epilepsy in phenotype and pathogenic mechanism, implied a clinical significance in early diagnosis and management.
    Type of Medium: Online Resource
    ISSN: 2001-1326 , 2001-1326
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2697013-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: International Journal of Cancer, Wiley, Vol. 134, No. 6 ( 2014-03-15), p. 1311-1322
    Abstract: What's new? ALX4 is a putative transcription factor involved in epithelial development. In this study, the authors examined whether the methylation status and function of ALX4 might play a role in lung cancer. They found that ALX4 was preferentially methylated in lung cancer, via CpG‐island hypermethylation. This, in turn resulted in a loss of ALX4 expression. When ALX4 was restored, it induced apoptosis and suppressed tumorigenicity in mice. These findings indicate that ALX4 acts as a novel tumor suppressor in lung cancer, which may aid in early detection and provide a potential therapeutic target.
    Type of Medium: Online Resource
    ISSN: 0020-7136 , 1097-0215
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2014
    detail.hit.zdb_id: 218257-9
    detail.hit.zdb_id: 1474822-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Wiley ; 2015
    In:  Molecular Carcinogenesis Vol. 54, No. 4 ( 2015-04), p. 312-321
    In: Molecular Carcinogenesis, Wiley, Vol. 54, No. 4 ( 2015-04), p. 312-321
    Abstract: The identification of the key genetic and epigenetic changes underlying lung carcinogenesis would aid effective early diagnosis and targeted therapies for lung cancer. In this study, we screened a novel hypermethylated gene ankyrin repeat domain 18B ( ANKRD18B ), to determine whether it is regulated by DNA methylation and clarify its biological and clinical implications in lung cancer. Methylation status and expression level were analyzed by methylation‐specific PCR, bisulfite genomic sequencing, and quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR). We detected ANKRD18B hypermethylation in 52 of 98 (53.1%) primary lung cancer tissues and in nine of 10 (90%) cell lines, whereas no methylation was seen in 10 normal lung tissue samples. ANKRD18B methylation was more frequently observed in patients with poor differentiation ( P   〈  0.05). Notably, 62 pairs of samples from patients whose tumor tissue showed hypermethylation of ANKRD18B exhibited the same aberrant methylation in 72.7% and 69.7% of their corresponding plasma and sputum samples, respectively; whereas no hypermethylation of ANKRD18B was detected in the sputum and plasma from patients whose tumor sample lacked this alteration. In addition, ANKRD18B mRNA expression was significantly decreased or silenced in lung cancer tissues and cell lines associated with hypermethylation of the ANKRD18B region. Demethylation agent 5‐aza‐2′‐deoxycytidine significantly increased ANKRD18B mRNA expression in lung cancer cell lines. Furthermore, overexpression of ANKRD18B suppressed lung cancer cell growth. These results suggest that the expression of ANKRD18B is regulated by CpG island hypermethylation in lung cancer. Our findings confirm the importance of the identification of new markers of epigenetic dysregulation in cancer. © 2013 Wiley Periodicals, Inc.
    Type of Medium: Online Resource
    ISSN: 0899-1987 , 1098-2744
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2015
    detail.hit.zdb_id: 2001984-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Wiley ; 2010
    In:  ChemInform Vol. 31, No. 32 ( 2010-06-03), p. no-no
    In: ChemInform, Wiley, Vol. 31, No. 32 ( 2010-06-03), p. no-no
    Type of Medium: Online Resource
    ISSN: 0931-7597 , 1522-2667
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2110203-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Journal of the Science of Food and Agriculture, Wiley, Vol. 88, No. 14 ( 2008-11), p. 2401-2413
    Type of Medium: Online Resource
    ISSN: 0022-5142 , 1097-0010
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2008
    detail.hit.zdb_id: 2001807-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Molecular Genetics & Genomic Medicine, Wiley, Vol. 8, No. 8 ( 2020-08)
    Abstract: Sarcopenia is a complex polygenic disease, and its molecular mechanism is still unclear. Whole lean body mass (WLBM) is a heritable trait predicting sarcopenia. To identify genomic loci underlying, we performed a whole‐exome sequencing (WES) of WLBM variation with high sequencing depth (more than 40*) in 101 Chinese subjects. We then replicated in the major findings in the large‐scale UK Biobank (UKB) cohort ( N  = 217,822) for WLBM. The results of four single‐nucleotide polymorphisms (SNPs) were significant both in the discovery stage and replication stage: SNP rs740681 (discovery p  = 1.66 × 10 –6 , replication p  = .05), rs2272303 (discovery p  = 3.20 × 10 –4 , replication p  = 3.10 × 10 –4 ), rs11170413 (discovery p  = 3.99 × 10 –4 , replication p  = 2.90 × 10 –4 ), and rs2272302 (discovery p  = 9.13 × 10 –4 , replication p  = 3.10 × 10 –4 ). We combined p values of the significant SNPs. Functional annotations highlighted two candidate genes, including FZR1 and SOAT2 , that may exert pleiotropic effects to the development of body mass. Our findings provide useful insights that further enhance our understanding of genetic interplay in sarcopenia.
    Type of Medium: Online Resource
    ISSN: 2324-9269 , 2324-9269
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2734884-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Wiley ; 2019
    In:  ChemCatChem Vol. 11, No. 3 ( 2019-02-06), p. 1112-1122
    In: ChemCatChem, Wiley, Vol. 11, No. 3 ( 2019-02-06), p. 1112-1122
    Abstract: Molybdenum disulfides are attractive sulfur‐tolerant catalysts suitable for the direct conversion of sulfur‐containing syngas, which avoids the expensive step of the deep desulfurization. However, the catalytic activity of MoS 2 ‐based catalysts is relatively low. To improve the activity, previous works have focused on modifying MoS 2 with various promoters and supports, but the structural aspects are largely overlooked. In this work, we investigated the active nature of the MoS 2 ‐based catalysts for the catalytic hydrogenation of carbon monoxide. Thus, the bulk MoS 2 with varied crystallite sizes was synthesized by the hydrothermal and the thermal decomposition methods. The catalysts before and after catalytic tests were characterized by in‐situ X‐ray diffraction, X‐ray photoelectron spectroscopy, and transmission electron microscope techniques. The CO hydrogenation under low‐temperature methanation conditions (The syngas with a H 2 /CO=2 and 40.0 ppm H 2 S, T=360 °C, and P=2 MPa) was applied to evaluate MoS 2 as a catalyst for converting syngas. The catalytic results indicate that the MoS 2 with smaller crystallite sizes exhibited a higher CO conversion. By correlating the structural propriety with the catalytic activity, a hexagonal‐prim‐shaped model was developed to describe different sites on the MoS 2 crystallite. Based on this model, the activity of different active sites on the bulk MoS 2 for CO hydrogenation decreased in the order of rim sites 〉 edge sites ≫ basal sites. The highest catalytic activity over the bulk MoS 2 with smallest particles was attributed to the highest exposure of the rim sites.
    Type of Medium: Online Resource
    ISSN: 1867-3880 , 1867-3899
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2019
    detail.hit.zdb_id: 2501161-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Cancer Communications, Wiley, Vol. 40, No. 1 ( 2020-01), p. 3-15
    Abstract: Indoleamine 2,3‐dioxygenase 1 (IDO1) and tryptophan (Trp) catabolism have been demonstrated to play an important role in tumor immunosuppression. This study examined the expression and catalytic activity of IDO1 in penile squamous cell carcinoma (PSCC) and explored their clinical significance. Methods IDO1 expression level, serum concentrations of Trp and kynurenine (Kyn) were examined in 114 PSCC patients by immunohistonchemistry and solid‐phase extraction‐liquid chromatography‐tandem mass spectrometry. The survival was analyzed using Kaplan‐Meier method and the log‐rank test. Hazard ratio of death was analyzed via univariate and multivariate Cox regression. Immune cell types were defined by principal component analysis. The correlativity was assessed by Pearson's correlation analysis. Results The expression level of IDO1 in PSCC cells was positively correlated with serum Kyn concentration and Kyn/Trp radio (KTR; both P   〈  0.001) but negatively correlated with serum Trp concentration ( P  = 0.001). Additionally, IDO1 up‐regulation in cancer cells and the increase of serum KTR were significantly associated with advanced N stage (both P   〈  0.001) and high pathologic grade ( P  = 0.008 and 0.032, respectively). High expression level of IDO1 in cancer cells and serum KTR were associated with short disease‐specific survival (both P   〈  0.001). However, besides N stage (hazard radio [HR], 6.926; 95% confidence interval [CI] , 2.458‐19.068; P   〈  0.001) and pathologic grade (HR, 2.194; 95% CI, 1.021‐4.529; P  = 0.038), only serum KTR (HR, 2.780; 95% CI, 1.066‐7.215; P  = 0.036) was an independent predictor for PSCC prognosis. IDO1 expression was positively correlated with the expression of interferon‐γ (IFNγ, P   〈  0.001) and immunosuppressive markers (programmed cell death protein 1, cytotoxic T‐lymphocyte‐associated protein 4 and programmed death‐ligand 1 and 2; all P   〈  0.05), and the infiltration of immune cells (including cytotoxic T lymphocytes, regulatory T lymphocytes, tumor‐associated macrophages, and myeloid‐derived suppressor cells; all P   〈  0.001) in PSCC tissues. Furthermore, the expression of IDO1 was induced by IFNγ in a dose‐dependent manner in PSCC cells. Conclusions IFNγ‐induced IDO1 plays a crucial role in immunoediting and immunosuppression in PSCC. Additionally, serum KTR, an indicator of IDO1 catabolic activity, can be utilized as an independent prognostic factor for PSCC.
    Type of Medium: Online Resource
    ISSN: 2523-3548 , 2523-3548
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2922913-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...